Skip to content

Effect of Virechana with Trivrit Modak and orally Shalmali Ghrita in abnormal menstrual bleeding

Clinical Evaluation of Virechana (Trivrit Modak) and Shalmali Ghrita in the management of Asrigdara ( Abnormal Uterine Bleeding)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045516
Enrollment
40
Registered
2022-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

Intervention1: Virechana with Trivrit Modak and Shalmali Ghrita Orally: Patientis subjected to Snehpaan(3-7days)first then sarwang snehan and swedan for 3 days. After this Virechana drug is administer

Sponsors

University Post Graduate Institute Of Ayurved Studies and Research
Lead Sponsor
Dr Apurva Joshi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)Excessive bleeding 2)Prolonged menstruation 3)Intermenstrual bleeding 4)Willingness of patients. 5)Patients who are Yogya for Virechan. (Decided by according to Dosha, Aushadh, Desha, kala, Satmaya, Agni Satva, Vaya, Bala, etc.)

Exclusion criteria

Exclusion criteria: 1)Bleeding due to erosion, fibroid & Polyp. 2)Patients having bleeding due to abortion. 3)Bleeding from the site other than the uterus. 4)Patients having Coagulation disorders. 5)Patient suffering from malignancies and chronic systemic diseases like, uncontrolled diabetes (above the range of 160-200 mg/dl), uncontrolled hypertension (Systolic blood pressure �Patients having STDs like Gonorrhoea, Syphilis, HIV/AIDS. �Patients using IUCD and Oral contraceptive pills (OCP) �Patients who are Ayogya for Virechana. �Patients having Hemoglobin less than 7.

Design outcomes

Primary

MeasureTime frame
Improvment in amount,duration of bleeding, intermenstrual bleeding, bodyache,Pain haemoglobin , Endometrium thicknessTimepoint: 60 days

Secondary

MeasureTime frame
Evaluate the efficacy of Virechana by Trivrit Modak and Shalmali Ghrita (orally) in the management of AsrigdaraTimepoint: 60 days

Countries

India

Contacts

Public ContactDr Apurva Joshi

University Post Graduate Institute Of Ayurved Studies and Research

vd_rashmi11@yahoo.com9782371381

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026